Business Description
OpGen Inc
NAICS : 423450
SIC : 5047
ISIN : US68373L2088
Description
OpGen Inc is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. It is developing molecular information products and services for healthcare settings, helping to guide clinicians with rapid and actionable information about life-threatening infections, improve patient outcomes, and decrease the spread of infections caused by MDROs. Its proprietary DNA tests and informatics address the rising threat of antibiotic resistance by helping physicians and other healthcare providers optimize care decisions for patients with acute infections. The company's product candidates and services combine its Acuitas molecular diagnostics and Acuitas Lighthouse informatics platform for use with its curated MDRO knowledge base.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.73 | |||||
| Equity-to-Asset | 0.55 | |||||
| Debt-to-Equity | 0.75 | |||||
| Debt-to-EBITDA | -0.25 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -79.17 | |||||
| Beneish M-Score | -3.29 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -56.7 | |||||
| 3-Year EBITDA Growth Rate | 47.4 | |||||
| 3-Year EPS without NRI Growth Rate | 58.8 | |||||
| 3-Year FCF Growth Rate | 59.9 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 55.48 | |||||
| 9-Day RSI | 51.35 | |||||
| 14-Day RSI | 49.26 | |||||
| 6-1 Month Momentum % | 43.04 | |||||
| 12-1 Month Momentum % | -13.95 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.45 | |||||
| Quick Ratio | 5.45 | |||||
| Cash Ratio | 2.77 | |||||
| Days Inventory | 442.01 | |||||
| Days Sales Outstanding | 35.35 | |||||
| Days Payable | 86.8 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -117.1 | |||||
| Shareholder Yield % | 15.78 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 4.34 | |||||
| Operating Margin % | -471.72 | |||||
| Net Margin % | -742.42 | |||||
| FCF Margin % | -495.44 | |||||
| ROA % | -150.01 | |||||
| ROIC % | -44 | |||||
| ROC (Joel Greenblatt) % | -340.22 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.36 | |||||
| PB Ratio | 2.54 | |||||
| Price-to-Tangible-Book | 2.52 | |||||
| EV-to-EBIT | -0.89 | |||||
| EV-to-EBITDA | -0.92 | |||||
| EV-to-Forward-EBITDA | -1.01 | |||||
| EV-to-Revenue | 6.48 | |||||
| EV-to-Forward-Revenue | 6.69 | |||||
| EV-to-FCF | -1.3 | |||||
| Price-to-Net-Current-Asset-Value | 10.74 | |||||
| Earnings Yield (Greenblatt) % | -112.36 | |||||
| FCF Yield % | -83.16 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
OpGen Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 1.162 | ||
| EPS (TTM) (€) | 0 | ||
| Beta | 0 | ||
| Volatility % | 207.28 | ||
| 14-Day RSI | 49.26 | ||
| 14-Day ATR (€) | 0.694825 | ||
| 20-Day SMA (€) | 4.0109 | ||
| 12-1 Month Momentum % | -13.95 | ||
| 52-Week Range (€) | 0.408 - 34 | ||
| Shares Outstanding (Mil) | 1.26 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
OpGen Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
OpGen Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
OpGen Inc Frequently Asked Questions
What is OpGen Inc(STU:650)'s stock price today?
The current price of STU:650 is €4.08. The 52 week high of STU:650 is €34.00 and 52 week low is €0.41.
When is next earnings date of OpGen Inc(STU:650)?
The next earnings date of OpGen Inc(STU:650) is 2025-02-15 Est..
Does OpGen Inc(STU:650) pay dividends? If so, how much?
OpGen Inc(STU:650) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers